ANIX — Anixa Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Anixa Biosciences, fiscal year end - October 31st, USD millions except per share, conversion factor applied.

	2020 October 31st	2021 October 31st	2022 October 31st	2023 October 31st	2024 October 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	9.06	35.7	29.7	23.8	19.9
Net Total Accounts Receivable
Net Total Receivables	0.002	—	—	0.27	0.173
Prepaid Expenses
Total Current Assets	9.37	36	30.2	25.4	21.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.054	0.254	0.212	0.166	0.229
Other Long Term Assets
Total Assets	9.45	36.3	30.4	25.5	21.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	1.19	1.27	2.04	2.03	2.5
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	0.692	0.82	1.36	1.19	1.59
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	8.76	35.4	29	24.3	20
Total Liabilities & Shareholders' Equity	9.45	36.3	30.4	25.5	21.6
Total Common Shares Outstanding
Total Preferred Shares Outstanding